# CORRESP — Anixa Biosciences Inc  (ANIX)  (CIK 0000715446)

> <strong>Anixa Biosciences Inc  (ANIX)  (CIK 0000715446) → SEC staff</strong> · filed 2025-09-26 · ticker ANIX · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001493152-25-015776
- **Form:** CORRESP
- **Filer:** Anixa Biosciences Inc  (ANIX)  (CIK 0000715446)
- **CIK:** 0000715446
- **Ticker:** ANIX
- **Filed:** 2025-09-26
- **SIC industry:** 2834
- **HQ:** San Jose, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/715446/000149315225015776/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=715446&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Anixa Biosciences Inc  (ANIX)  (CIK 0000715446)

- UPLOAD — 2025-09-16 — /comment-letter/0000000000-25-010013

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Anixa Biosciences Inc  (ANIX)  (CIK 0000715446) (CIK 0000715446), filed 2025-09-26, accession 0001493152-25-015776. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001493152-25-015776.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*